TC
IDYA icon

Trust Company’s IDEAYA Biosciences IDYA Stock Holding History

Trust Company’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$745 Hold
20
– – ﹤0.01% 656
2026
Q1 		$666 Hold
20
– – ﹤0.01% 643
2025
Q4 		$691 Buy
+20
New +$638 ﹤0.01% 606

Other funds holding IDYA

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Trust Company's IDYA Position: Q2 2026 in Review

Trust Company held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 20 shares worth $745. The position accounts for ﹤0.01% of the portfolio, ranked #656.

Trust Company first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 23 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Trust Company held 20 shares of IDEAYA Biosciences worth $745 as of Q2 2026.
  • Trust Company left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #656 holding.
  • Trust Company first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 23 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.